Dr Ainsley Goff graduated in Medicine at the University of Sydney, Faculty of Medicine and Health in October 2020. Ainsley joined Central Sydney Cardiology (CSC) via our Graduate Entry program as an Administrative Assistant.
Royal Prince Alfred’s Michele McGrady is proof that it’s never too late to switch careers and follow your heart – even if it means 14 years of additional study and…
New research from Harvard Medical School has shown that the results of treatment of paroxysmal and persistent atrial fibrillation (AF) by catheter ablation are much better when co-existent sleep apnoea (OSA) is treated (JACC July 23 2013).
Heart failure, a condition where the heart is unable to pump blood effectively to meet the needs of the body, leads to fluid retention, breathlessness, tiredness and impacts on the quality of life of those affected by it.
Bicuspid aortic valve (BAV) is the most common congenital cardiac malformation, with a prevalence of 1-2% in the general population and results in greater morbidity than all other congenital heart diseases combined.
Obstructive sleep apnoea (OSA) is common in patients with atrial fibrillation (AF) and has been shown to be a risk factor for AF in a number of studies of patients with and without structural heart disease.